Treatment options for isolated aortic valve insufficiency: a review
Aortic insufficiency (AI) is a valvular disease with increasing prevalence in older patients. The modern era provides numerous options for the management of AI which is explored here. Traditional interventions included aortic valve replacement with either mechanical or bioprosthetic aortic valves. W...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-04-01
|
| Series: | Frontiers in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1381102/full |
| _version_ | 1797214762035052544 |
|---|---|
| author | Salem Argaw Nasim Azizgolshani David Blitzer Hiroo Takayama Isaac George Luigi Pirelli |
| author_facet | Salem Argaw Nasim Azizgolshani David Blitzer Hiroo Takayama Isaac George Luigi Pirelli |
| author_sort | Salem Argaw |
| collection | DOAJ |
| description | Aortic insufficiency (AI) is a valvular disease with increasing prevalence in older patients. The modern era provides numerous options for the management of AI which is explored here. Traditional interventions included aortic valve replacement with either mechanical or bioprosthetic aortic valves. While the former is known for its durability, it has grown out of favor due to the potential complications of anticoagulation. The preference for bioprosthetic valves is thus on the rise, especially with the advancements of transcatheter technology and the use of valve-in-valve therapy. Surgical options are also no longer limited to replacement but include complex techniques such as those required for aortic valve repair, Ozaki neocuspidization, Ross procedure and valve-sparring aortic root repair. Transcatheter options for the management of AI are not commercially available currently; however, preliminary data from ad-hoc trials, showed promising results and potential use of transcatheter technology in a variety of patients with pure AI. |
| first_indexed | 2024-04-24T11:19:19Z |
| format | Article |
| id | doaj.art-826c4c40df754b43a111ce4130115a66 |
| institution | Directory Open Access Journal |
| issn | 2297-055X |
| language | English |
| last_indexed | 2024-04-24T11:19:19Z |
| publishDate | 2024-04-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Cardiovascular Medicine |
| spelling | doaj.art-826c4c40df754b43a111ce4130115a662024-04-11T04:53:14ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2024-04-011110.3389/fcvm.2024.13811021381102Treatment options for isolated aortic valve insufficiency: a reviewSalem ArgawNasim AzizgolshaniDavid BlitzerHiroo TakayamaIsaac GeorgeLuigi PirelliAortic insufficiency (AI) is a valvular disease with increasing prevalence in older patients. The modern era provides numerous options for the management of AI which is explored here. Traditional interventions included aortic valve replacement with either mechanical or bioprosthetic aortic valves. While the former is known for its durability, it has grown out of favor due to the potential complications of anticoagulation. The preference for bioprosthetic valves is thus on the rise, especially with the advancements of transcatheter technology and the use of valve-in-valve therapy. Surgical options are also no longer limited to replacement but include complex techniques such as those required for aortic valve repair, Ozaki neocuspidization, Ross procedure and valve-sparring aortic root repair. Transcatheter options for the management of AI are not commercially available currently; however, preliminary data from ad-hoc trials, showed promising results and potential use of transcatheter technology in a variety of patients with pure AI.https://www.frontiersin.org/articles/10.3389/fcvm.2024.1381102/fullaortic insufficiencyaortic regurgitationaortic valve replacementaortic valve repairtranscatheter management of AIaortic prosthesis |
| spellingShingle | Salem Argaw Nasim Azizgolshani David Blitzer Hiroo Takayama Isaac George Luigi Pirelli Treatment options for isolated aortic valve insufficiency: a review Frontiers in Cardiovascular Medicine aortic insufficiency aortic regurgitation aortic valve replacement aortic valve repair transcatheter management of AI aortic prosthesis |
| title | Treatment options for isolated aortic valve insufficiency: a review |
| title_full | Treatment options for isolated aortic valve insufficiency: a review |
| title_fullStr | Treatment options for isolated aortic valve insufficiency: a review |
| title_full_unstemmed | Treatment options for isolated aortic valve insufficiency: a review |
| title_short | Treatment options for isolated aortic valve insufficiency: a review |
| title_sort | treatment options for isolated aortic valve insufficiency a review |
| topic | aortic insufficiency aortic regurgitation aortic valve replacement aortic valve repair transcatheter management of AI aortic prosthesis |
| url | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1381102/full |
| work_keys_str_mv | AT salemargaw treatmentoptionsforisolatedaorticvalveinsufficiencyareview AT nasimazizgolshani treatmentoptionsforisolatedaorticvalveinsufficiencyareview AT davidblitzer treatmentoptionsforisolatedaorticvalveinsufficiencyareview AT hirootakayama treatmentoptionsforisolatedaorticvalveinsufficiencyareview AT isaacgeorge treatmentoptionsforisolatedaorticvalveinsufficiencyareview AT luigipirelli treatmentoptionsforisolatedaorticvalveinsufficiencyareview |